The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
FluMist
Influenza Vaccine Live Intranasal · INFLUENZA A VIRUS A/NORWAY/31694/2022 (H1N1) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA A VIRUS A/PERTH/722/2024 (H3N2) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL · Spray · Nasal · MedImmune, LLC
NDC 66019-0112-10 · 10 APPLICATOR in 1 CARTON / .2 mL in 1 APPLICATOR · BLA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$254.40
Reported to Texas DSHS · 2026 annual filing · AstraZeneca
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BLA125020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Influenza Vaccine Live Intranasal (Spray)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| MedImmune, U.K. Limited | INFLUENZA B VIRUS 1000000 [FFU]/125mL; INFLUENZA A VIRUS 1000000 [FFU]/125mL | Jul 22, 2026 | Sep 2, 2026 |
| MedImmune, LLC | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 (H1N1) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA A VIRUS A/DARWIN/1369/2025 (H3N2) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA B VIRUS B/PERTH/115/2025 LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL | Jul 24, 2026 | Aug 28, 2026 |
| MedImmune, LLC | INFLUENZA A VIRUS A/NORWAY/31694/2022 (H1N1) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA A VIRUS A/PERTH/722/2024 (H3N2) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL | Jul 15, 2026 | Jul 22, 2026 |
| MedImmune, U.K. Limited | INFLUENZA A VIRUS 1000000 [FFU]/125mL; INFLUENZA B VIRUS 1000000 [FFU]/125mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "FluMist — NDC 66019-0112-10," retrieved September 3, 2026, https://drugdashboards.com/drug/66019011210.
Free to cite with attribution — see how the data is put together.